In line with the hypothesis that NK cell-mediated tumor cell killing induced by Ab-retargeting provides the antigen necessary for priming of tumor antigen-specific CD8 T-cell responses, we showed that the response against the neoepitope Adpgk was completely abrogated when NK cells were depleted during Ab-retargeting. This evidence concerns the gene ADPGK and neoplasm.